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Abstract
Background: Technology used for the purification of recombinant proteins is a key issue for the biochemical and 
structural analyses of proteins. In general, affinity tags, such as glutathione-S-transferase or six-histidines, are used to 
purify recombinant proteins. Since such affinity tags often interfere negatively with the structural and functional 
analyses of proteins, they are usually removed by treatment with proteases. Previously, Dr. H. Mao reported self-
cleavage purification of a target protein by fusing the sortase protein to its N-terminal end, and subsequently obtained 
tag-free recombinant protein following expression in Escherichia coli. This method, however, is yet to be applied to the 
cell-free based protein production.
Results: The histidine tag-based self-cleavage method for purifying proteins produced by the wheat cell-free protein 
synthesis system showed high background, low recovery, and unexpected cleavage between the N-terminally fused 
sortase and target protein during the protein synthesis. Addition of calcium chelator BAPTA to the cell-free reaction 
inhibited the cleavage. In order to adapt the sortase-based purification method to the cell-free system, we next used 
biotin as the affinity tag. The biotinylated sortase self-cleavage purification (BISOP) method provided tag-free, highly 
purified proteins due to improved recovery of proteins from the resin. The N-terminal sequence analysis of the GFP 
produced by the BISOP method revealed that the cleavage indeed occurred at the right cleavage site. Using this 
method, we also successfully purified the E2 heterocomplex of USE2N and USE2v1. The c-terminal src kinase (CSK) 
obtained by the BISOP method showed high activity in phosphorylating the Src protein. Furthermore, we 
demonstrated that this method is suitable for automatically synthesizing and purifying proteins using robots.
Conclusion: We demonstrated that the newly developed BISOP method is very useful for obtaining high quality, tag-
free recombinant proteins, produced using the cell-free system, for biochemical and structural analyses.
Background
Technology used for purifying a recombinant protein has
a significant impact on its biochemical function, struc-
tural properties, and other aspects, such as generating an
antibody against the protein. Currently available, estab-
lished purification methods generally attach an affinity
tag to the N-terminus or C-terminus end of the target
protein, and then recover the target protein by affinity
chromatography [1]. Purification tags used today are clas-
sified into peptide-tags and protein-tags based on their
nature and form. His-tag, a typical and globally the most
used peptide-tag, is highly effective in purifying the
tagged protein by using immobilized metal affinity chro-
matography, such as nickel sepharose [2]. The glutathi-
one-S-transferase (GST) tag, a typical protein-tag, has a
high specific binding capacity for glutathione, and is, gen-
erally, known to have little or no effect on the activity of
the fused recombinant protein [3]. In both cases, how-
ever, production of tag-free recombinant protein requires
treatment with a protease, such as PreScission or TEV
protease. Therefore, in order to purify a tag-free recombi-
nant protein multiple chromatography steps are neces-
sary.
Currently, there are only a few recombinant protein
purification methods that combine affinity purification,
cleavage, and separation of the fusion partner in one-step.
One such one-step purification method was reported by
Mao [4], in which the catalytic core of the transpeptidase
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sortase A (srtA, amino acid residues from 60-206), found
in the cell envelope of Staphylococcus aureus [5,6], was
used for fusion with the target protein. The SrtA enzyme
is known to catalytically cleave the Thr-Gly bond of its
recognition motif LPXTG (X is any amino acid) in the
presence of calcium and triglycine [6-9]. Thus, the puri-
fied target protein eluted off the affinity column has only
an extra Gly residue on the N-terminus end. This excel-
lent approach was designed for the purification of recom-
binant proteins expressed in Escherichia coli cells.
However, as discussed in that report [4], the fusion pro-
tein was partially self-cleaved during the expression,
probably because of the difficulty in controlling the con-
centration of calcium in the living cells. Inability to sup-
press the srtA activity during the expression of the fused
recombinant protein in E. coli was, therefore, a major
limiting factor for using this otherwise excellent approach
as a general tool for the production and purification of
recombinant proteins.
At present, several types of cell-free protein production
systems have been reported as alternative methods for
obtaining recombinant proteins [see 10 and 11 for
reviews]. In this regard, it is noteworthy that we are also
developing wheat embryo based cell-free system for in
vitro protein production [12-14]. Cell-free protein pro-
duction is very flexible because it utilizes only the transla-
tional machinery of the cell without other factors, such as
DNA replication and metabolic pathways, of the living
system. The cell-free system, thus, could simply be modi-
fied by the addition or subtraction of reagents. In this
study, we have adopted the self-cleavage activity of srtA
in the wheat cell-free system for the production of tag-
free recombinant proteins, and demonstrated an
improved self-cleavage purification method by incorpo-
rating biotinylation reagents and calcium chelates in the
cell-free synthesis system.
Results and Discussion
Self-cleavage activity of srtA during the cell-free protein 
synthesis
First, based on the previous report, we constructed the
expression vector pEU-His-srtA-GW by inserting the
DNA fragment required for the Gateway (GW) recombi-
nation technology into the previously described wheat
germ cell-free expression vector pEU-E01 [13]. The Gate-
way system allows easy recombination of the targeted
genes. The srtA cleavage site, LPETG, was introduced in
the forward PCR primer according to the instructions
provided with the Gateway system (Figure 1A). To test
the self-cleavage purification system, we selected the
human protein kinases and malaria vaccine candidate
Pfs25 (Plasmodium falciparum 25 kDa ookinete surface
antigen precursor) as candidate proteins because they are
very important proteins for practical use. PCR products
of the coding regions of Pfs25 and six protein kinases
were amplified, and each PCR amplified fragment was
individually inserted into the pDONR221 vector by BP
recombination reaction. Subsequently, the inserted
LPETG-gene fragment was cloned into the pEU-His-
srtA-GW vector by LR recombination reaction, resulting
in a pEU-His-srtA-LPETG-gene plasmid. These pEU-
His-srtA-LPETG-gene plasmids were then used for 14C-
Leu-labeled protein synthesis using the wheat cell-free
system. Unfortunately, in all cases, 20 to 40% of the syn-
thesized proteins were cleaved during the cell-free syn-
thesis (Figure 1B). The cleavage rate was dependent on
the type of the gene used in creating the plasmid con-
struct. For example, cleavage of Pfs25 (S25 lane in Figure
1B) and GFP (Figure 1C) during the protein synthesis
process were very low, whereas almost 40% of the synthe-
sized SGK495 protein was cleaved during the cell-free
synthesis. Since calcium supplementation is known to
induce the srtA activity [4,9], the cell-free system was
treated with the calcium chelator, BAPTA (Figure 1C).
Treatment with more than 4 mM BAPTA dramatically
blocked the inexpedient cleavage of SGK495. However,
protein synthesis was inhibited as the BAPTA concentra-
tion was increased (Figure 1D). For example, levels of
SGK495 and GFP proteins produced in the presence of 5
mM BAPTA were approximately 20% and 30%, respec-
tively, of their respective levels in the absence of BAPTA.
In other proteins, the synthesis conditions in the pres-
ence of 1 and 3 mM BAPTA were investigated (Figure 1E
and 1F). By comparing the results of the BAPTA-concen-
tration dependent blocking of the srtA activity and inhi-
bition of the protein synthesis, we concluded that 1 mM
BAPTA is optimal for the cell-free synthesis of srtA-
fusion proteins, because at this concentration of BAPTA
the recovery of all full-length srtA fusion proteins
improved by approximately 10-20% without any major
inhibition of the protein synthesis.
Self-cleavage purification of His-srtA-fusion proteins
A total of eight plasmid constructs, each containing a dif-
ferent gene (generalized here as pEU-His-srtA-LPETG-
gene), were used for the cell-free protein production and
self-cleavage purification studies, and the results are
shown in Figure 1G. Out of eight proteins, three proteins,
GFP, p38g and Pfs25, clearly eluted from a nickel-nitrilo-
triacetic acid (Ni-NTA) sepharose column, whereas other
five proteins could not be recovered in the eluted fraction
(Figure 1G, left panel). To confirm protein synthesis and
self-cleavage, column resins of all samples were analyzed
by SDS-PAGE after boiling with SDS-sample buffer (Fig-
ure 1G, right panel). Surprisingly, even though AMPKa1,
CSK, SGK and SGK495 were synthesized and self-cleaved
on the column resin, their cleaved forms were not eluted
off the resin. We could not find the RIPK3 protein in theMatsunaga et al. BMC Biotechnology 2010, 10:42
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Figure 1 Synthesis of srtA-fusion proteins using the wheat germ cell-free system. A. Schematic representation of the pEU-His-srtA-LPETG-Gene 
plasmids created using the Gateway system. B. Autoradiogram of SDS-PAGE of proteins synthesized using the cell-free system in the presence of [14C] 
Leu. Lane M, Protein MW standards labeled by using [14C]-containing felt pen. C. Autoradiogram of [14C] Leu incorporated GFP and SGK495 proteins 
synthesized by the wheat cell-free system in the presence of the Ca2+ chelating reagent BAPTA. The number represents concentration (mM) of BAPTA 
used in the protein synthesis reaction. Arrowheads denote the sizes of the full-length proteins. D. Rate of synthesis of the full-length protein and pro-
ductivity of GFP (pink-colored bar and red-colored line) and SGK495 (purple-colored bar and blue-colored line) in the presence of different concen-
trations of BAPTA. E. Autoradiogram of [14C]-Leu incorporated proteins synthesized by the cell-free system in the presence of BAPTA. Asterisk denotes 
the sizes of the full-length proteins. F. Rate of synthesis of the full-length protein and productivity of proteins in the presence of different concentra-
tions of BAPTA. Productivities of total synthesized and full-length proteins indicated as blue and red bars respectively. G. Purifications of proteins by 
the cell-free synthesis using the pEU-His-srtA-LPETG-Gene plasmid constructs. CBB-stained protein bands on the SDS-PAGE gel of the eluted (left pan-
el) and resin-bound (right) target proteins are indicated using asterisk. Arrow represents the cleaved His-tagged srtA. Lane M (both panels): Protein 
MW standards.
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eluted or in the resin-bound fraction, suggesting that this
protein was expressed at a very low level. In addition,
purity of the protein in the eluted fraction was not high,
as there were several similar protein contaminants in
every lane. Furthermore, many proteins bound to the Ni-
NTA resin (right panel in Figure 1G). These results sug-
gested that further technical improvements were neces-
sary to achieve high quality purified proteins with high-
efficiency from the cell-free based His-srtA system.
Biotinylated sortase self-cleavage purification (BISOP)
Recently we successfully adapted the biotin-labeling sys-
tem of E. coli biotin ligase and biotin to the wheat cell-
free protein synthesis system [15]. The biotinylation reac-
tion modifies a specific lysine residue at the biotin liga-
tion site (bls: GLNDIFEAQKIEWHE, the underline is the
ligation site). The biotinylated proteins could be directly
used for an assay without further purification because of
very low biotin concentration. Since the His-tag based
approach showed many contaminated proteins in the
eluted fraction of the Ni-NTA column, we next used the
biotin-labeled tag for protein purification. For this pur-
pose, we constructed the pEU-BISOP-LPETG-GFP plas-
mid based on the pEU-His-srtA-LPETG-GFP vector as
shown in Figure 1A and 2A. Next, we compared whether
the His-tagged or the biotin-tagged protein could be bet-
ter purified by the sortase self-cleavage method, pro-
cessed either manually or using automated robots to
eliminate any human error. Clearly, on the CBB-stained
SDS-PAGE, a single major protein band (with low back-
ground) was found in the eluted fraction following the
sortase self-cleavage of the biotin-tagged srtA fusion pro-
tein; in contrast, contaminating proteins were found
along with the major protein band in the eluted fraction
of the self-cleaved His-tagged srtA fusion protein (Figure
2B). Reaction performance of robot for His-srtA-LPETG-
GFP or BISOP-LPETG-GFP was 63 or 58% of recovery,
52 or 88% of purity, and 68 or 62 μg of yield respectively.
These results suggest that the BISOP method is better
suited for producing tag-free purified proteins by the cell-
free system.
Next, to examine whether the number of bls has any
effect on the purification, two vectors, one having a single
bls and the other having double bls, were constructed
(Figure 2A). Coding regions of GFP, Pfs25 and CSK were
individually cloned into each one of these two vectors,
and then the resultant recombinant plasmids were used
for the protein synthesis using the cell-free system. Stain-
ing with Alexa488-labeled streptavidin revealed slight
mobility shifts for proteins containing double bls, as com-
pared to those containing single bls (Figure 2C). We did
not observe any difference between the single and double
bls containing proteins with respect to biotinylation, elu-
tion and resin binding characteristics. Similar to the self-
cleavage purification of GFP (shown in Figure 2B), all
three eluted proteins were highly purified (left panel in
Figure 2D). The higher purity of proteins obtained using
the BISOP method might be due to the presence of very
few contaminating proteins on the streptavidin-conju-
gated resin (compare right panel in Figure 2D with Figure
1G). Interestingly, the CSK protein, prepared by the
BISOP method was eluted of the resin, whereas with the
His-tag based method it was not found in the eluted frac-
tion (Figure 1G). Total amounts of purified GFP, S25 and
CSK by the BISOP method were 44, 37, and 55 μg per
reaction respectively. Also full-length GFP, S25 and CSK
proteins remaining on the column were approximately 6,
3 and 3 μg respectively, and cleaved S25 and CSK proteins
on the column were 3 and 3 μg respectively. These data
means that rate of target proteins remaining on the col-
umn was approximately 15%. Next, the BISOP method
was used for purifying several other proteins. For this
purpose, four protein kinase genes were individually
inserted into the Gateway system vector pEU-BISOP-
GW following the procedures described above, and the
results are shown in Figure 2E. Both SGK495 and
AMPKa1, which were not recovered earlier from the
resin when the His-tag based method was used (Fgiure
1G), were also purified by the BISOP method (Figure 2E).
Total amounts of purified CSK, SGK495, AMPKa1 and
p38g by the BISOP method were 55, 42, 24 and 57 μg per
reaction respectively. In addition, analysis of the N-termi-
nal sequence of the GFP protein purified by the BISOP
revealed the expected cleavage of the Thr-Gly bond of the
inserted LPETG sortase-recognition site (Figure 2F).
These results suggested that the BISOP method would be
suitable for the purification of the cell-free produced pro-
teins with high efficiency and purity.
Purification of E2 heterocomplex by BISOP
Analysis of protein complex is one of important targets
for their structural and biochemical analysis. Thus, next
we examined whether a protein heterocomplex, co-
expressed using the wheat cell-free system, could be puri-
fied by the BISOP method. To test this notion, we next
co-expressed UBE2N and UBE2v1, two proteins forming
the heterodimer complex of the ubiquitin-conjugate (E2)
enzyme [16], using the BISOP method. Specific complex
formation between these two proteins produced by the
cell-free system has already been reported [15]. At first,
we confirmed co-expression of the biotinylated srtA-
LPETG-UBE2N and UBE2v1 (tag-free form) by incorpo-
rating 14C-Leu during the cell-free synthesis (Figure 3A).
Notably, we recovered the E2 heterocomplex consisting
of UBE2N and UBE2v1 when both UBE2v1 and srtA-
LPETG-UBE2N were co-expressed using the cell-free
system and then purified by the BISOP method (Figures
3B and 3C). The protein band corresponding to UBE2v1Matsunaga et al. BMC Biotechnology 2010, 10:42
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Figure 2 Preparation of proteins by the biotinylated-sortase self-cleavage purification (BISOP) method. A. Scheme for creating the pEU-
BISOP-LPETG-gene plasmids using the Gateway recombination method. The LPETG-fused target gene containing entry clone plasmid was recom-
bined with the pEU-BISOP-GW vector by using the Gateway LR reaction. B. CBB-stained SDS-PAGE comparing the His- or biotin-tagged GFP protein 
(indicated using an asterisk) purified manually or by using an automated robot. Lane M: Protein MW standards. C. Biotinylation of GFP, Pfs25 (S25) and 
CSK proteins synthesized by the cell-free system with vectors having a single (S) or a double (D) biotin ligation site. Biotinylated proteins were detected 
by labeling the separated protein bands with streaptavidin-Alexa488 as described in the text, followed by scanning using the Typhoon Imager. D. 
CBB-stained eluted (left panel) and resin-bound (right panel) proteins. Arrow indicates the cleaved biotinylated srtA protease left on the resin. Samples 
(5 or 10 μL in left or right panel respectively) were loaded on the gel. E. Left panel: Biotinylated proteins were detected by streaptavidin-Alexa488; 
Right panel: CBB-stained proteins purified by the BISOP method. Samples (5 μL) were loaded on the gel. F. Amino acid sequences from the N-terminal 
end of GFP purified by the BISOP method were determined by using an amino acid sequencer (asterisks, upper panel). Rounds indicate the number 
of Edman degradation cycle. Underlined amino acid sequence in the lower panel shows the determined sequence. Arrowhead indicates the site 
cleaved by the sortase enzyme.
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was however not found when the biotinylated srtA-
LPETG-UBE2N was expressed alone. Therefore, this
result suggests that the BISOP method would be useful
for purification of protein complexes produced by the
cell-free system.
Activity of CSK purified by the BISOP method
It is very important that the purification method provide
functionally active protein. We, therefore, investigated
whether the CSK protein purified using the BISOP
method could specifically phosphorylate the Tyr-530 res-
idue of human Src protein (Swiss-Prot no. P12931) [17].
For this purpose, biotinylated Src was synthesized by the
cell-free system and the synthesized protein was partially
purified using the magnetic streptavidin-conjugated
beads. The bead-bound Src was then treated with [32P]-
labeled or unlabeled ATP and the CSK protein that was
purified by the BISOP method. Both autoradiogram of
the SDS-PAGE separated proteins from the reaction mix
containing [32P]-labeled ATP and immunoblot analysis of
the SDS-PAGE separated proteins from the reaction mix
containing the unlabeled ATP using the specific anti-
phospho-Src antibody showed specific phosphorylation
of the Y530 residue of Src by CSK (Figure 4). These
results suggest that BISOP would be suitable for the in
vitro synthesis of active proteins.
Conclusion
The cell-free system is an easy to use method for synthe-
sizing recombinant proteins. In this study, we have devel-
oped a new biotinylated-sortase self-cleavage purification
(BISOP) method to achieve high quality purification of
several proteins, including a protein heterocomplex,
without any affinity tag. In addition, we showed that this
method could be automated using robots. Results of this
study indicate that the combination of the cell-free pro-
tein synthesis system and BISOP could provide a simple
and easy method for the preparation of high quality
recombinant proteins without any affinity tag. Since the
cell-free system is suitable for high-throughput protein
production, this combined method could also be utilized
at the genome-wide level.
Methods
General
The following procedures have been either described in
detail or cited [13,15,18,19]: isolation of the wheat germs
and preparation of the extract, generation of the DNA
template by polymerase chain reaction (PCR) using split-
primers, parallel synthesis of mRNA and protein, estima-
tion of the amount of protein synthesized by densitomet-
ric scanning of the Coomassie brilliant blue (CBB)-
stained band and autoradiogram of radiolabeled-pro-
teins, and detection of biotinylated proteins using
Alexa488-conjugated streptavidin (Invitrogen) and the
Figure 3 Application of BISOP method to purify the UBE2N/
UBE2v1 heterocomplex co-expressed by the cell-free system. A. 
The proteins were synthesized from the plasmid constructs using the 
cell-free system in the presence of 14C-Leu and the synthesized pro-
teins were detected by autoradiography after electrophoresis on a 
SDS-PAGE (5-20% gradient gel). Lane 1: Proteins synthesized from a 
mixture of pEU-BISOP-LPETG-UBE2N and pEU-UBE2v1 plasmids; Lane 
2: Protein synthesized using the pEU-BISOP-LPETG-UBE2N plasmid; 
Lane 3: Protein synthesized using the pEU-UBE2v1 plasmid; Lane 4: 
Sortase cleavage of lane 1 by the BISOP method; Lane 5: Sortase cleav-
age of lane 2 by the method; and Lane M, Protein MW standards. As-
terisk, arrow and arrowhead indicate srtA-LPETG-UBE2N, G-UBE2N and 
UBE2v1 (tag-free), respectively. B. BISOP was performed after expres-
sion of biotinylated srtA-LPETG-UBE2N with (lane 1) or without UBE2v1 
(lane 2). The eluted proteins were separated on the SDS-PAGE gel and 
then stained with CBB. Arrow and arrowhead indicate the purified G-
UBE2N and UBE2v1, respectively. C. Scheme for the preparation of 
UBE2N/UBE2v1 heterocomplex by BISOP.
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Typhoon Imager (GE Healthcare) fitted with 532 nm
laser and 526 emission filter.
Template genes
The cDNA clone of the malarial parasite Plasmodium fal-
ciparum  25 kDa ookinete surface antigen precursor
(Pfs25) was kindly provided by Dr. Tsuboi (Cell-free
Research and Technology Center, Ehime University).
cDNAs of GFP, UBE2N (GenBank accession no.
BC003365), and UBE2v1 (GenBank accession no.
BC000468) were described in our previous reports
[15,18]. Mammalian gene collection (MGC) cDNA clones
of CSK (BC104875), SGK (BC001263), SGK495
(BC007835), AMPKa1 (BC048980), p38g (BC015741),
RIPK3 (BC062584) and Src (BC011566) were also used in
this study.
Construction of the srtA-based self-cleavage vector
DNA fragment encoding the mature-form of srtA (corre-
sponding to amino acids 60-206, GenBank accession no.
AF162687) was artificially synthesized and inserted into
the pUC57 to create the plasmid pUC57-srtA-EcoRV-
SpeI by the GenScript Corporation (Boston). The
pUC57-srtA-EcoRV-SpeI plasmid as used as a template
to amplify the mature srtA fragment (DraI-His or bls-
srtA-EcoRV-SpeI) by PCR using the following pair of
primers: M13(M3) (5'-GTAAAACGACGGCCAGT) and
DraI-A-His-srtA (5'-GAGATTTAAATGGCCAGCAGC
CATCACCATCACCATCATAGCAGCGGCCTGGTGC
CGC) or M13(M3) and Dra1-A-bls-srtA (5'-GAGAT
TTAAATGGCCAGCAGCGGCCTGAACGACATCTTC
GAGGCCCAGAAGATCGAGTGGCACGAAAGCAGC G
GCCTGGTGCCGC). The DraI-A-His-srtA primer
included 6 × His-tag codons and a DraI restriction
enzyme site, and the DraI-A-bls-srtA primer included a
bls (biotin ligase site) recognition sequence and a DraI
restriction enzyme site. After digestion with DraI and
SpeI enzymes each fragment was inserted into the EcoRV
and SpeI sites in pEU-E01-MCS provided by CellFree Sci-
ences, Ltd http://www.cfsciences.com/eg/index.html to
create pEU-His-srtA-MCS and pEU-BISOP-MCS plas-
mids, respectively. To create the Gateway®-based plas-
mids pEU-His-srtA-GW and pEU-BISOP-GW, DNA
fragment needed for Gateway®  recombination cloning
technology (Invitorogen) was inserted into the EcoRV site
of the pEU-His-srtA-MCS and pEU-BISOP-MCS plas-
mids. PCR reaction was performed by PrimeStar enzyme
according to instruction (Takara Bio, Otsu, Japan). Nucle-
otide sequences of the DNA inserts in all plasmid con-
structs were subsequently confirmed by using the ABI
PRISM 310 Genetic Analyzer using the BigDye termina-
tor v1.1 Cycle sequence kit (Applied Biosystems, Foster
City, CA).
Plasmid construction for the cell-free protein production
We introduced the srtA self-cleavage site (DNA encoding
for the amino acid sequence LPETG) into the recombi-
nant plasmid construct for the cell-free production of
proteins. The DNA fragments coding the respective pro-
tein were amplified by PCR using two gene specific prim-
ers: forward primer attB1-LPETG-Gene (5'-
GGGGACAAGTTTGTACAAAAAAGCAGGCTTC-
CTGCCCGAGACCGGCatg(n)19; uppercase, lower-
cased and bold sequences indicated common, gene
specific and LPETG sequences, respectively; n represent
gene specific sequence) and reverse primer attB2-Gene
(5'-GGGGACCACTTTGTACAAGAAAGCTG-
GGTCxxxnnnnnnnnnnnnnnnn; xxx is the complemen-
tary sequence of the stop codon; n represent gene specific
sequence). PCR reaction was performed using the Prime-
Star enzyme (Takara Bio, Otsu, Japan) and following the
supplier's instructions. The amplified attB1-LPETG-
Gene-attB2 fragments were inserted into the donor vec-
tor pDONR221 by BP reaction to generate the entry plas-
mids. The LPETG-fusion Gene in the entry plasmid was
transferred to the pEU-His-srtA-GW or pEU-BISOP-
GW by LR reaction to generate the pEU based-plasmid
clones. BP and LR reactions were carried out according to
the instructions provided by the supplier of the reagents
(Invitrogen, Carlsbad, CA). Nucleotide sequences of the
DNA inserts in all the plasmid constructs were subse-
quently confirmed by using the ABI PRISM 310 Genetic
Analyzer described method above.
Cell-free protein production
For the cell-free protein production, we employed the
wheat germ cell-free protein expression system using the
bilayer translation method described previously [18,19].
Cell-free protein production was carried out using the
ENDEXT® Wheat Germ Expression S Kit and according
to the instructions provided by the supplier (CellFree Sci-
ences Co., Ltd., Matsuyama, Japan). Briefly, 250 μL of
transcriptional mixture [80 mM HEPES-KOH, pH 7.8, 16
mM magnesium acetate, 2 mM spermidine, 10 mM DTT,
2.5 mM NTP mix, 1 U/μL SP6 RNA polymerase (Pro-
mega, Madison, WI), 1 U/μL RNase inhibitor, RNasin
(Promega), and 100 ng/μL undigested plasmid DNA] was
incubated at 37°C for 6 h, and then mixed with 250 μL of
wheat embryo extract (120 A 260/mL, CellFree Sciences
Co., Ltd.) and 1 μL of 20 mg/mL creatine kinase (Roche
Applied Science, Indianapolis, IN). This mixture, called
the translational mixture, was then carefully transferred
to the bottom of the well of a 6-well tissue culture plate
(Whatman Inc., Clifton, NJ) that already contained 5.5
mL of TSB (30 mM HEPES-KOH, pH 7.8, 100 mM potas-
sium acetate, 2.7 mM magnesium acetate, 0.4 mM sper-
midine, 2.5 mM DTT, 0.3 mM amino acid mix, 1.2 mM
ATP, 0.25 mM GTP and 16 mM creatine phosphate) byMatsunaga et al. BMC Biotechnology 2010, 10:42
http://www.biomedcentral.com/1472-6750/10/42
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inserting the pipette tip down to the bottom of the well,
thereby creating two distinct layers. The plate was then
covered with the sealing film, and was incubated at 17°C
for 18 hr without shaking. For the calcium chelating
experiment, 1 mM BAPTA (1,2-bis(o-aminophe-
noxy)ethane-N,N,N',N'-tetraacetic acid) (Sigma-Aldrich,
St Louis, MO) was added to both the translational mix-
ture and TSB. For biotin labeling of proteins [15,20], 2 μg
of biotin protein ligase (BirA, GenBank accession no.
NP_0312927) produced by the wheat cell-free system and
6 μM D-biotin (Nacalai Tesque, Kyoto, Japan) were added
to the bottom translational mixture.
For co-expression of the biotinylated srtA-LPETG-
UBE2N and UBE2v1, the cell-free production method
was slightly modified. Each translation mixture was pre-
pared independently and pre-incubated at 26°C for 30
min, following which they were mixed, and were subse-
quently used in the bilayer translation reaction as
described above.
Self-cleavage purification of proteins produced by the cell-
free system
Reaction mixture (6 mL) from the cell-free expression
system described above was mixed with 100 μL of Ni-
NTA sepharose (GE Healthcare) or 100 μL of streptavi-
din-sepharose (GE helthcase). The sepharose beads were
pre-equilibrated with phosphate buffered saline (PBS) for
4 to 6 hours (His tag) or 30 min (BISOP) at 4°C. Sephar-
ose bead-captured srtA-fusion proteins were collected by
centrifugation (3,000 × g) and the beads were washed
three times with PBS buffer. Self-cleavage purification of
the target protein was performed by incubation of the
beads with 100 μL of Elution buffer [20 mM Tris-HCl (pH
7.5), 5 mM Tri-Gly (Sigma-Aldrich), 5 mM CaCb, 150
mM NaCl, 1 mM DTT and 2% glycerol] for 4 hours at
16°C. The buffer-bead mixture was then transferred into
a micro spin-column (GE Healthcare) and the eluted frac-
tion was recovered by flash centrifuge (3,000 × g) at 4°C.
The N-terminal end of the eluted GFP was determined by
amino acid sequence analysis using the Applied Biosys-
tems ABI 473A protein sequencer and according to the
instructions provided by Applied Biosystems.
The cell-free protein production and self-cleavage puri-
fication were also carried out using an automatic robot,
Protemist DTII (CellFree Sciences Co., Ltd.), basically
according to manufacturer's instructions. Addition of
biotinylation reagents and BAPTA were also carried out
as mentioned above.
Phosphorylation assay
The phosphorylation assay was mainly performed
according to the previous published methods [13,21]. To
assay for phosphorylation of the biotinylated Src by CSK,
40 μl of the reaction mixture was mixed with 15 μl of bio-
tin magnetic beads (Promega, MI), and was washed twice
with PBS buffer and once with protein kinase (PK) buffer
[50 mM Tris-HCl (pH 7.6), 500 mM potassium acetate,
50 mM MgCl2, 0.1 mM DTT]. Beads were suspended in
10 μl PK buffer supplemented with cold ATP (for immu-
noblot) or [γ-32P]-ATP (for autoradiogram), and CSK
purified using the BISOP method, UBE2N or commer-
cially available GST-CSK fusion protein (purchased from
Carna Biosciences Inc., Kobe) was added in the reaction
mixture. The mixtures were incubated at 37°C for 30 min,
following which they were boiled in the SDS-denaturing
buffer and the proteins were separated on 12.5% SDS-
polyacrylamide gel. Autoradiogram of Src phosphoryla-
tion was analyzed by BAS-2500 (FUJIFILM, Tokyo,
Japan). For immunoblot analysis, proteins were trans-
ferred from the SDS-PAGE gel to PVDF membrane (Mil-
lipore Bedford, MA, USA) following standard
procedures. The blots were then processed using the
Immobilon Western detection reagents (Millipore) and
antibody against phosphorylated Src (Y527) or Src (Cell
Signaling Technology, Beverly, MA) according to the
manufacturer's procedure. The anti-phospho-Src (Y527)
antibody recognizes the phosphorylated Y530 residue in
human Src.
Abbreviations
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